previous compound ID: 1014 next compound
InChIKey: IWUCXVSUMQZMFG-AFCXAGJDSA-N
SMILES: C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "SD Macknight" "D Rotin" "J Goepp" "R Robert" "J Liao" "B Kus" "DY Thomas" "JW Hanrahan" "GW Carlile"

chemical graph of compound 1014





CID is 37542
synonyms found at PubChem are:
ribavirin, 36791-04-5, Tribavirin, Virazole, Rebetol, Ribavirine, Copegus, Vilona, Ribamide, Ribamidil, Ribasphere, Viramid, Ribamidyl, Ribavirina, Ribavirinum, Rebetron, Varazid, RTCA, Ribavirin Capsules, Ribavirine [INN-French], Ribavirinum [INN-Latin], Ribavirina [INN-Spanish], ICN-1229, Rebretron, Ribovirin, Viramide, Virazid, Virazide, Ribav, 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide, Cotronak, Ravanex, Ribacine, Ribavirin [USAN:INN], C-Virin, DRG-0028, Ribasphere (TN), Virazole (TN), 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, Copegus (TN), Rebetol (TN), UNII-49717AWG6K, Ribavirin (Copegus), 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide, HSDB 6513, SCH 18908, RBV, BRN 0892462, Ribavarin, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide, CHEBI:63580, 49717AWG6K, RG-964, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide, Ro-20-9963, Virazole (Ribavirin) Inhalation Solution, 1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-, R-964, DSSTox_CID_3557, EN300-59237, Ro 20-9963/000, NSC 163039, R 9644, DSSTox_RID_77081, DSSTox_GSID_23557, RTC, 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-, 1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide, 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide, 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide, 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide, SMR000058315, SR-01000076112, Ribavirine;, NSC163039, Drug: Ribavirin, KS-1104, Ribavirin [USAN:USP:INN:BAN], Drug: Ribavirin, Ribavirin,(S), NCGC00015904-02, Ribavirin, antiviral, CAS-36791-04-5, Vilona (TN), PubChem14187, Spectrum_001826, 4pb1, ribofluranosyl carboxamide, AC1L1XXZ, AC1Q1IDC, AC1Q4ZGS, Prestwick3_000993, Spectrum3_001876, Spectrum4_001252, Spectrum5_002075, 1-|A-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide, D0DI8X, D0H3WI, SCHEMBL3727, CHEMBL1643, Ribavirin (JAN/USP/INN), Lopac0_001063, BSPBio_001085, BSPBio_003352, KBioGR_001804, KBioSS_002331, cid_37542, MLS000028486, MLS002222317, DivK1c_000782, SPECTRUM1503938, Ribavirin (JP17/USP/INN), BPBio1_001195, GTPL6842, DTXSID8023557, CTK7J7594, HMS502H04, KBio1_000782, KBio2_002328, KBio2_004896, KBio2_007464, KBio3_002854, BIB6306, IWUCXVSUMQZMFG-AFCXAGJDSA-N, MolPort-002-507-104, NINDS_000782, HMS2090L15, HMS2094O09, HMS2098G07, HMS2232P07, HMS3263E08, HMS3715G07, Pharmakon1600-01503938, BB_NC-00567, HY-B0434, ZINC1035331, Tox21_110259, Tox21_200967, Tox21_501063, BDBM50154375, CCG-38985, MFCD00058564, NSC758650, s2504, AKOS001715163, Tox21_110259_1, API0004062, CS-2540, DB00811, GS-3572, LP01063, LS-1241, MCULE-9495128592, NSC-758650, IDI1_000782, SMP1_000261, NCGC00090726-01, NCGC00090726-03, NCGC00090726-04, NCGC00090726-05, NCGC00090726-06, NCGC00090726-07, NCGC00090726-08, NCGC00090726-09, NCGC00090726-12, NCGC00258520-01, NCGC00261748-01, AJ-24715, AK-49185, AS-34178, BR-49185, CC-34249, CPD000058315, SAM002548967, SC-12159, ZB015662, BCP0726000138, SBI-0051033.P003, AB0068936, AX8005387, ST2413783, AB00430481, EU-0101063, FT-0082885, FT-0630597, FT-0649908, R0077, D00423, J10190, M-7546, AB00430481-15, AB00430481-16, AB00430481_17, AB00430481_18, RBI034 (2-5A antisense compound) + Ribavirin, 1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide, 791R045, AA-504/07617051, C-14783, SR-01000721904, SR-01000076112-2, SR-01000076112-3, SR-01000076112-4, SR-01000721904-2, BRD-K60369935-001-02-7, BRD-K60369935-001-18-3, SR-01000076112-11, 1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, Ribavirin, British Pharmacopoeia (BP) Reference Standard, Z1522567185, 1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide, Ribavirin, European Pharmacopoeia (EP) Reference Standard, Ribavirin, United States Pharmacopeia (USP) Reference Standard, Ribavirin, Pharmaceutical Secondary Standard; Certified Reference Material, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide, 437710-49-1, 66510-90-5